Rimbach, Germany

Alfred Popelak


Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 1976

Loading Chart...
3 patents (USPTO):Explore Patents

Title: **Alfred Popelak: Innovator in Therapeutic Compositions**

Introduction

Alfred Popelak is a distinguished inventor based in Rimbach, Germany. Known for his significant contributions to the field of pharmaceuticals, he has been the driving force behind several innovative therapeutic compositions. With a total of three patents to his name, Popelak's work is notable for its potential impact on treating cardiovascular and circulatory diseases.

Latest Patents

Popelak's latest patents include innovative compounds that target specific health issues. One of his patents focuses on "3-Alkyl-4-sulfamoyl-aniline therapeutic compositions," introducing new 3-alkyl-4-sulfamoyl-aniline compounds which show promise in medical applications. Additionally, he has developed "1,2,3,4-tetra-hydrocarbazole derivatives," which are particularly effective as inhibitors of androgenic β-receptors. These compounds are beneficial for the treatment and prophylaxis of cardiac and circulatory diseases.

Career Highlights

Alfred Popelak is associated with Boehringer Mannheim GmbH, a leading company in the pharmaceutical sector. His tenure at this organization has allowed him to leverage his expertise in medicinal chemistry and drug development, contributing to advancements in therapeutic options available for patients.

Collaborations

Throughout his career, Popelak has collaborated with esteemed colleagues, including Kurt Stach and Ansgar Lerch. These partnerships have fostered an environment of innovation and have been instrumental in the successful development of his patented compositions.

Conclusion

In summary, Alfred Popelak stands out as a prominent inventor in the pharmaceutical industry. His innovative work and collaborations led to the development of compositions that hold significant promise for improving healthcare, particularly in the treatment of cardiac and circulatory diseases. With his continued focus on innovation, Popelak’s contributions are likely to leave a lasting mark in the field of therapeutic compositions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…